$TDC

MCMILLAN STEPHEN sold $300K of TDC

MCMILLAN STEPHEN (President and CEO) sold 10,000 shares of TERADATA CORP /DE/ (TDC) at $30.02 ($0.30M total) on 2026-09-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · MCMILLAN STEPHEN
Published Sep 17, 2026, 6:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 6:14 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDC
Neutral
medium confidence
Mentioned
$TDC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDCNeutralLow
01

Why it matters

The disclosed sale is modest relative to the insider's total holdings and follows a pre‑arranged plan, suggesting limited predictive power.

02

Market read

Primary relevance is to traders tracking insider activity; broader market impact is negligible.

03

What to watch

The 10b5‑1 plan pre‑arranges sales, reducing the informational content of the transaction.

Relevance 3/10Novelty 6/10Timing: post‑filing 2026‑09‑15

Background

Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$TDCNeutralMedium confidence
Context

President and CEO Stephen McMillan sold 10,000 shares for $300,170 via a 10b5‑1 plan.

Expected impact

Potential modest downward pressure if market interprets as negative signal.

Evidence & confidence

Sale size is modest relative to holdings; executed under pre‑arranged plan, limiting informational value.

Market effects

Minimal impact on the data‑analytics sector.

No significant regional effect.

Limited to investors tracking insider activity.

Counterpoint

Sale could be routine liquidity management, not a bearish sign.

Key entities

  • Teradata Corp

    Data‑analytics and cloud‑based services provider.

  • Stephen McMillan

    President and CEO of Teradata.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MANHMed

Manhattan Associates, Agilysys, Guidewire Software, Pegasystems, and Teradata Stocks Trade Up, What You Need To Know

Shares of Manhattan Associates, Agilysys, Guidewire Software, Pegasystems, and Teradata rose in afternoon trading after strong quarterly earnings and optimistic corporate commentary about AI-driven growth in enterprise software. Salesforce, CrowdStrike, and Okta reported significant AI-related revenue increases, easing investor concerns about AI disruption. Pegasystems' stock is down 36.2% year-to-date but saw a 6.2% increase on the day.

$TDCMed

Read Analyst Questions From Teradata’s Q2 Earnings Call

Teradata (TDC) reported Q2 revenue of $410M, above the $396.1M estimate, and adjusted EPS of $0.69 versus $0.56. Adjusted operating income was $88M. Management cited strong recurring revenue and margin improvement, plus a shift in on-premise contract revenue recognition that left sales flat YoY. Q3 revenue guidance midpoint was $395.2M, below estimates.

$TDCMed

Teradata Q2 Earnings Call Highlights

Teradata (NYSE:TDC) reported Q2 gross margin up 220 bps to 60.5% and recurring revenue gross margin up 30 bps to 67.8%, attributing outperformance to on-premise revenue recognition timing. Net cash rose to $323 million. The company repurchased about $40 million of stock and paid off $450 million of a term loan. It reaffirmed full-year guidance, raised non-GAAP EPS to $2.65-$2.73, and guided Q3 recurring revenue down 4%-2% and total revenue down 6%-4%.

$TDCMed

Why Is Teradata Stock Falling on Wednesday? - Teradata (NYSE:TDC)

Teradata (TDC) reported Q2 adjusted EPS of 69 cents, above the 56-cent estimate, and sales of $410 million versus $397.1 million expected. For Q3, it guided adjusted EPS of 55 to 59 cents and sales of $391.0 to $399.4 million, both below estimates. FY2026 adjusted EPS was raised to $2.65-$2.73. Barclays cut its price forecast to $27. Shares fell 21.2% to $27.11.